general oncology

You have access
Pretargeting: A Path Forward for Radioimmunotherapy
Sarah M. Cheal, Sebastian K. Chung, Brett A. Vaughn, Nai-Kong V. Cheung and Steven M. Larson

Journal of Nuclear Medicine September 1, 2022, 63 (9) 1302-1315; DOI: https://doi.org/10.2967/jnumed.121.262186
You have access
The Importance of Training, Accreditation, and Guidelines for the Practice of Theranostics: The Australian Perspective
Sze Ting Lee, Louise M. Emmett, David A. Pattison, Michael S. Hofman, Dale L. Bailey, Melissa J. Latter, Roslyn J. Francis and Andrew M. Scott

Journal of Nuclear Medicine June 1, 2022, 63 (6) 819-822; DOI: https://doi.org/10.2967/jnumed.122.263996
You have access
In Vitro Evaluation of Molecular Tumor Targets in Nuclear Medicine: Immunohistochemistry Is One Option, but Under Which Conditions?
Jean Claude Reubi

Journal of Nuclear Medicine December 1, 2017, 58 (12) 1885-1887; DOI: https://doi.org/10.2967/jnumed.117.197582
You have access
PET/CT Imaging and Human Papilloma Virus–Positive Oropharyngeal Squamous Cell Cancer: Evolving Clinical Imaging Paradigm
Rathan M. Subramaniam, Krishna C. Alluri, Abdel K. Tahari, Nafi Aygun and Harry Quon

Journal of Nuclear Medicine March 1, 2014, 55 (3) 431-438; DOI: https://doi.org/10.2967/jnumed.113.125542

Main menu